The U.S. is in "big danger" of falling behind in vaccine technology research as government funding declines and vaccine ...

The global mRNA quality monitoring market size was valued at USD 1.28 billion in 2024 and is predicted to hit around USD 2.5 ...

Ongoing federal support for mRNA technology and research could make good on a longstanding presidential promise to cure cancer, according to Jeff Coller, Bloomberg Distinguished Professor of RNA ...

NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...

A paradox of today’s era is that, from gene editing to space research to computing, the world is living through a golden age ...

Stanford Medicine investigators have unearthed the biological process by which mRNA-based vaccines for COVID-19 can cause ...

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. recently terminated $500 million in federal funding for developing mRNA vaccines, but don’t be fooled into thinking these life-saving ...

Vials of the Pfizer-BioNTech COVID-19 vaccine are shown in 2023. It was formulated using mRNA technology. Lee S. Weissman USA TODAY NETWORK As a longtime pediatrician in South Carolina, I am deeply ...

Russian scientists have produced the first three test batches of a newly developed cancer vaccine at the Gamaleya Institute ...